The name on an international health insurance policy is usually a brand, and a brand is not a balance sheet. Behind it there is very often a second company that carries the risk, a third that administers the claims, and two or three separate regulators watching different parts of the arrangement. This is not concealment: the structure is disclosed, and it is disclosed in the documents most buyers do not read.
It matters because the questions that determine whether a policy is any good are questions about the risk carrier, not the brand. Who is obliged to pay the claim. Who supervises their solvency. Whether they are licensed in the country you live in. Where a dispute goes when the claim is refused. None of those can be answered from a logo, and all of them can be answered in about ten minutes from the policy documents.
There is also a practical reason the structure exists at all, and it is the same reason an international plan can be sold in a country that prohibits foreign insurers from writing local business.
Three roles that one brand can hide
Almost every international medical policy involves at least two of the following, and often all three.
The intermediary arranges the cover. It may be a broker, an appointed representative or a distributor, and it is regulated as an intermediary — for conduct, disclosure and sales practice — rather than for its ability to pay claims. It holds no risk.
The managing general agent sits between the two. An MGA holds delegated authority from an insurer to manufacture and price products, accept risks, issue policies and frequently to handle claims in the insurer's name. To the customer it looks exactly like an insurer. It is not one.
The insurer, or risk carrier, is the entity contractually obliged to pay. It holds the regulatory capital, is supervised by a prudential regulator, and is the party whose failure would actually cost you something.
The worked example: a William Russell health policy
The insurance product information document for William Russell's international health plans, version 1 dated 10 November 2025, names two companies in its header rather than one, and then explains why.
William Russell Europe SRL arranges the cover. It is registered with the Belgian Financial Services and Markets Authority under number 0731.975.658 RPM, and its UK branch is authorised and regulated by the Financial Conduct Authority under reference 973067. That is the intermediary.
The risk is underwritten by AWP Health & Life SA, registered in Saint-Ouen, France, and regulated by the Autorité de Contrôle Prudentiel et de Résolution, the French prudential supervisor. That is the insurer.
So a plan bought from a British-sounding brand, arranged through a Belgian company with a UK-regulated branch, is underwritten in France under French prudential supervision. Every part of that is disclosed on the first page of a two-page document. None of it is apparent from the brand.
The MGA model
HCI Group Global describes itself as a managing general agent that manufactures and distributes private medical insurance internationally, operating a family of brands aimed at distinct populations — expatriates, seafarers and aviation crew — under names including Integra Global, Health Protect, MarineSure Health, OceanCare, PilotCare and NIMBL.
The NIMBL policy wording dated May 2026 sets the structure out with unusual clarity. The insurer is MGEN, a French mutual governed by the French mutual insurance code and regulated by the ACPR, or MGEN Portugal, a Portuguese insurance company supervised by the Portuguese insurance and pension funds authority. Which of the two carries a given member's risk is confirmed on that member's certificate of insurance. The administrator is HealthCare International Europe GmbH, based in Germany, regulated by BaFin and registered as an insurance intermediary with the Dortmund Chamber of Industry and Commerce; the UK entity is separately authorised by the FCA.
The complaints wording follows the same logic and is the most useful part of the document. Complaints go first to the FCA-authorised UK company and are handled primarily under FCA rules; the MGA states that for certain types of complaint the insurer is ultimately responsible, and that the member is free to approach the insurer directly. The final escalation route is an insurance mediation body in France or in Portugal, depending on which insurer holds the risk.
Two members holding what appears to be the same product can therefore have different insurers, different prudential regulators and different ombudsmen. The certificate of insurance is the only place that difference is visible.
Fronting, and why it exists
Fronting is the arrangement in which a locally licensed insurer issues the policy and then cedes most or all of the risk to an international carrier that cannot write the business directly. It exists because a large number of jurisdictions prohibit non-admitted insurance — cover written by an insurer that holds no local licence.
The Gulf is the clearest case. Practitioner commentary is consistent that the UAE prohibits non-admitted insurers from writing local risks including health, and that substantially similar prohibitions apply across the other GCC states. Dubai's Law No. 11 of 2013 makes the point structurally rather than by implication: health insurance activity requires authorisation from the Dubai Health Authority, and the law's definition of an insurance company requires an entity licensed in the UAE to conduct insurance business and authorised by the DHA. An offshore carrier fails both gates, however good its plan is.
Fronting is the recognised response. A locally licensed insurer issues the primary policy, satisfying the licence requirement and the residence-permit check, and reinsures the risk internationally. UAE law does not restrict foreign reinsurance of UAE risks, so the route works there. Saudi Arabia restricts foreign reinsurance as well as direct writing, which narrows it considerably. The practical consequence for Gulf residents is set out in the guides to health insurance in the UAE and Qatar, Kuwait and the wider Gulf: the normal structure is a locally admitted compliant base policy plus an international layer, not international cover as a substitute.
Now Health International runs a visible version of the same logic across territories, naming different underwriters by region — Starr International (Europe) Limited, Sompo Insurance Singapore, AXA General Insurance Hong Kong and Arabia Insurance Company for the UAE — with the DFSA, the Malta Financial Services Authority and the FCA among the regulators referenced. One brand, one product range, several risk carriers, chosen by where the member lives.
The mirror image is a provider declining to sell at all. VUMI's own site tells visitors from certain locations that it cannot provide cover to individuals, corporations and expatriates with permanent residency there — a licensing constraint expressed as a geographic restriction. Morgan Price excludes the UK and the UAE from the area of cover of its international product line, which have separate local arrangements.
Trade names, administrators and split risk
Two further patterns are common enough to expect.
APRIL International's MyHealth International range is administered by APRIL International Care France, registered with ORIAS, the French intermediary register, under number 07 008 000. The underwriters named are Groupama Gan Vie and Chubb European Group SE — two carriers rather than one, which usually indicates that different benefit lines sit on different paper.
Blue Cross Blue Shield Global Solutions, until recently GeoBlue, is a trade name for the international health insurance programmes of Worldwide Insurance Services, an independent licensee of the Blue Cross Blue Shield Association, with the risk underwritten by 4 Ever Life. The GeoBlue brand is being retired by the end of 2027 following a rebrand announced on 30 September 2025, so both names will circulate for some time. That change is a naming exercise rather than a change of risk carrier, which is precisely the distinction covered in when your insurer is acquired or rebranded.
The due diligence that is actually worth doing
Brand recognition is a weak proxy for security, and network size is weaker still — four of the largest international insurers each claim a network of over two million providers, using four different nouns, which makes the figure useless for comparison. Three questions do more work than any of that.
Who carries the risk? Find the insurer named in the insurance product information document and on the certificate of insurance, not the name in the header of the brochure. Where the insurer varies by member or by territory, establish which one is yours. Then assess that entity, not the brand — insurer solvency ratings and due diligence sets out what the ratings do and do not tell you.
Who regulates them, and where? The prudential regulator of the insurer determines the solvency regime standing behind the claims promise, and it is frequently in a different country from the intermediary's regulator. Separately, establish whether that insurer is admitted in the country where you actually live, because that is a different question again with consequences for tax, for local mandates and for enforceability — see admitted versus non-admitted insurance and the practical position in visa stage versus residence stage cover.
Where does a complaint go? Establish the escalation chain before you need it: which entity handles the first complaint, under which regulator's rules, which entity is ultimately responsible for claims decisions, and which ombudsman or mediation body sits at the end. On a fronted or MGA-distributed policy this chain crosses at least two jurisdictions, and working it out during a refused claim is the worst possible time to start. The process itself is covered in declined claims and how to appeal.
None of this changes which plan is right for you — that remains a question of plan architecture and benefits. It changes how much confidence the answer deserves.
Frequently asked questions
How do I find out who actually underwrites my policy?
Start with the insurance product information document and the certificate of insurance rather than the marketing material. Both are required to identify the risk carrier. A William Russell health IPID, for example, names two companies in its header — the arranging intermediary and the underwriter — and sets out the regulator of each. On some MGA-distributed products the insurer varies by member, so the certificate of insurance is the only document that tells you which of several possible carriers holds your particular risk.
What is a managing general agent?
A managing general agent, or MGA, is an intermediary holding delegated authority from an insurer to design products, underwrite risks, issue policies and often handle claims in the insurer's name. HCI Group Global operates on this basis, with policies underwritten by the French mutual MGEN. The commercial effect is that the customer-facing brand, the product design and the service all come from the MGA, while the obligation to pay claims and the regulatory capital behind it sit with the insurer.
What does fronting mean in insurance?
Fronting is an arrangement in which a locally licensed insurer issues the policy in a market where it is legally required, then transfers most or all of the risk to an international reinsurer that could not write the business directly. It exists because many jurisdictions prohibit non-admitted insurance — cover written by an insurer without a local licence. Fronting is the mechanism that allows an internationally designed plan to be issued on locally compliant paper.
Does it matter that my insurer is in a different country from my broker?
It matters for three practical reasons. The insurer's regulator determines the solvency regime standing behind your claims, which is not the same thing as your intermediary's regulator. The complaints and ombudsman route generally follows the insurer for disputes about the claim itself and the intermediary for disputes about sales and service. And the insurer's domicile determines whether the policy is admitted in the country where you live, which affects tax treatment and whether the cover satisfies any local mandate.
Is a policy from an MGA less secure than one from an insurer directly?
Not inherently. The security of the promise depends on the insurer standing behind it, not on the distribution model, and MGA-distributed products are frequently underwritten by large mutuals or established carriers. What changes is the number of parties and therefore the number of things worth checking: the insurer's financial strength and regulator, the MGA's own authorisation, whether the delegated authority covers claims handling, and where each type of complaint goes.
Where do I complain if my international health claim is refused?
The route depends on the structure. On an MGA-distributed policy the MGA typically handles complaints first under its own regulator's rules, with the insurer ultimately responsible for certain categories, and the ombudsman route then follows the insurer's jurisdiction. Where the insurer is French the dispute goes to a French mediation body; where it is Portuguese, to a Portuguese one. Establish that chain before you need it, because it is not obvious from the brand and it is rarely on the website.
This guide is general information only and does not constitute financial, legal, medical or tax advice. Global Investments is not authorised by the Financial Conduct Authority. Insurance products, benefit schedules and premiums are revised regularly, and mandatory health insurance requirements change frequently — in several jurisdictions they are described differently even between official sources. Nothing here is a recommendation of any product or insurer. Confirm the legal position with the relevant regulator or a locally qualified adviser, and confirm cover terms with the insurer, before acting.